Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지
DOI QR코드

DOI QR Code

Comparison of minimally invasive surfactant therapy with intubation surfactant administration and extubation for treating preterm infants with respiratory distress syndrome: a randomized clinical trial

  • 투고 : 2021.03.17
  • 심사 : 2021.07.07
  • 발행 : 2022.04.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Respiratory distress syndrome (RDS) is a common cause of hospitalization and death in preterm infants who require surfactant treatment and respiratory support. Purpose: This study aimed to compare the clinical outcomes of minimally invasive surfactant therapy (MIST) and the INtubation, SURfactant administration, and Extubation (INSURE) technique in preterm infants with RDS. Methods: In this clinical trial, 112 preterm infants born at 28-36 weeks of gestation and diagnosed with RDS randomly received 200-mg/kg surfactant by MIST or the INSURE method. In the MIST group, surfactant was administered using a thin catheter (5F feeding tube); in the INSURE group, surfactant was administered after intubation using a feeding tube and the tracheal tube was removed after positive pressure ventilation was started. Nasal continuous positive airway pressure was applied in both groups for respiratory support and the postprocedure clinical outcomes were compared. Results: The mean hospitalization time was shorter for infants in the MIST group than for those in the INSURE group (9.19±1.72 days vs. 10.21±2.15 days, P=0.006). Patent ductus arteriosus was less frequent in the MIST group (14.3% vs. 30.4%, P=0.041). Desaturation during surfactant administration occurred less commonly in the MIST group (19.6% vs. 39.3%, P=0.023). There were no significant intergroup differences in other early or late complications. Conclusion: These results suggest that surfactant administration using MIST could be a good replacement for INSURE in preterm infants with RDS since its use reduced the hospitalization time and the number of side effects.

키워드

과제정보

This article was extracted from a dissertation by Dr. Sajad Ghahremani to obtain a doctorate in pediatrics. The authors express their appreciation to NICU staff and the Vicechancellor of Research and Technology of Hamadan University of Medical Sciences.

참고문헌

  1. Condo V, Cipriani S, Colnaghi M, Bellu R, Zanini R, Bulfoni C, et al. Neonatal respiratory distress syndrome: are risk factors the same in preterm and term infants? J Matern Fetal Neonatal Med 2017;30:1267-72. https://doi.org/10.1080/14767058.2016.1210597
  2. Rubarth LB, Quinn J. Respiratory development and respiratory distress syndrome. Neonatal Netw 2015;34:231-8. https://doi.org/10.1891/0730-0832.34.4.231
  3. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrom K, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med 1994;331:1051-5. https://doi.org/10.1056/NEJM199410203311603
  4. Kumar P, Denson SE, Mancuso TJ, Committee on F, Newborn SOA, Pain M. Premedication for nonemergency endotracheal intubation in the neonate. Pediatrics 2010;125:608-15. https://doi.org/10.1542/peds.2009-2863
  5. Pfister RH, Soll RF. Initial respiratory support of preterm infants: the role of CPAP, the INSURE method, and noninvasive ventilation. Clin Perinatol 2012;39:459-81. https://doi.org/10.1016/j.clp.2012.06.015
  6. Dargaville PA, Aiyappan A, Cornelius A, Williams C, De Paoli AG. Preliminary evaluation of a new technique of minimally invasive surfactant therapy. Arch Dis Child Fetal Neonatal Ed 2011;96:F243-8.
  7. Shim GH. Update of minimally invasive surfactant therapy. Korean J Pediatr 2017;60:273-81. https://doi.org/10.3345/kjp.2017.60.9.273
  8. Klotz D, Porcaro U, Fleck T, Fuchs H. European perspective on less invasive surfactant administration-a survey. Eur J Pediatr 2017;176:147-54. https://doi.org/10.1007/s00431-016-2812-9
  9. Jeffreys E, Hunt K, Dassios T, Greenough A. UK survey of less invasive surfactant administration. Arch Dis Child Fetal Neonatal Ed 2019;104:F567.
  10. Dargaville PA, Kamlin CO, De Paoli AG, Carlin JB, Orsini F, Soll RF, et al. The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation. BMC Pediatr 2014;14:213. https://doi.org/10.1186/1471-2431-14-213
  11. Aldana-Aguirre JC, Pinto M, Featherstone RM, Kumar M. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2017;102:F17-23. https://doi.org/10.1136/archdischild-2015-310299
  12. Hartel C, Paul P, Hanke K, Humberg A, Kribs A, Mehler K, et al. Less invasive surfactant administration and complications of preterm birth. Sci Rep 2018;8:8333. https://doi.org/10.1038/s41598-018-26437-x
  13. Mosayebi Z, Kadivar M, Taheri-Derakhsh N, Nariman S, Mahdi Marashi S, Farsi Z, et al. A randomized trial comparing surfactant administration using INSURE technique and the minimally invasive surfactant therapy in preterm infants (28 to 34 weeks of gestation) with respiratory distress syndrome. J Compr Ped 2017;8:e60724.
  14. Olivier F, Nadeau S, Belanger S, Julien AS, Masse E, Ali N, et al. Efficacy of minimally invasive surfactant therapy in moderate and late preterm infants: a multicentre randomized control trial. Paediatr Child Health 2017;22:120-4. https://doi.org/10.1093/pch/pxx033
  15. Dargaville PA, Aiyappan A, De Paoli AG, Kuschel CA, Kamlin CO, Carlin JB, et al. Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal Ed 2013;98:F122-6. https://doi.org/10.1136/archdischild-2011-301314
  16. de Kort E, Kusters S, Niemarkt H, van Pul C, Reiss I, Simons S, et al. Quality assessment and response to less invasive surfactant administration (LISA) without sedation. Pediatr Res 2020;87:125-30. https://doi.org/10.1038/s41390-019-0552-z
  17. Al Ethawi Y. Preliminary evaluation of a new technique of minimally invasive surfactant therapy. J Clin Neonatol 2012;1:66-8. https://doi.org/10.4103/2249-4847.96744
  18. Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics 2013;131:e502-9. https://doi.org/10.1542/peds.2012-0603
  19. Kribs A, Roll C, Gopel W, Wieg C, Groneck P, Laux R, et al. Nonintubated surfactant application vs conventional therapy in extremely preterm infants: a randomized clinical trial. JAMA Pediatr 2015;169:723-30. https://doi.org/10.1001/jamapediatrics.2015.0504
  20. Mirnia K, Heidarzadeh M, Hoseini MB, Sadeghnia A, Akrami F, Balila M, et al. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial in Alzahra hospital. Iran J Neonatol 2013;4:5-9.
  21. Aguar M, Cernada M, Brugada M, Gimeno A, Gutierrez A, Vento M. Minimally invasive surfactant therapy with a gastric tube is as effective as the intubation, surfactant, and extubation technique in preterm babies. Acta Paediatr 2014;103:e229-33. https://doi.org/10.1111/apa.12611
  22. Niemarkt HJ, Kuypers E, Jellema R, Ophelders D, Hutten M, Nikiforou M, et al. Effects of less-invasive surfactant administration on oxygenation, pulmonary surfactant distribution, and lung compliance in spontaneously breathing preterm lambs. Pediatr Res 2014;76:166-70. https://doi.org/10.1038/pr.2014.66
  23. De Luca D, Minucci A, Gentile L, Capoluongo ED. Surfactant inadvertent loss using feeding catheters or endotracheal tubes. Am J Perinatol 2014;31:209-12. https://doi.org/10.1055/s-0033-1345262
  24. Janssen LC, Van Der Spil J, van Kaam AH, Dieleman JP, Andriessen P, Onland W, et al. Minimally invasive surfactant therapy failure: risk factors and outcome. Arch Dis Child Fetal Neonatal Ed 2019;104:F636-42. https://doi.org/10.1136/archdischild-2018-316258
  25. Tomar RS, Ghuliani R, Yadav D. Effect of surfactant therapy using orogastric tube for tracheal catheterization in preterm newborns with respiratory distress. Indian J Pediatr 2017;84:257-61. https://doi.org/10.1007/s12098-016-2278-9
  26. Dunn MS, Kaempf J, de Klerk A, de Klerk R, Reilly M, Howard D, et al. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics 2011;128:e1069-76. https://doi.org/10.1542/peds.2010-3848
  27. Bugter IAL, Janssen LCE, Dieleman J, Kramer BW, Andriessen P, Niemarkt HJ. Introduction of less invasive surfactant administration (LISA), impact on diagnostic and therapeutic procedures in early life: a historical cohort study. BMC Pediatrics 2020;20:421. https://doi.org/10.1186/s12887-020-02325-0
  28. Wang XA, Chen LJ, Chen SM, Su PH, Chen JY. Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome. Pediatr Neonatol 2020;61:210-5. https://doi.org/10.1016/j.pedneo.2019.11.002
  29. Klebermass-Schrehof K, Wald M, Schwindt J, Grill A, Prusa AR, Haiden N, et al. Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity. Neonatology 2013;103:252-8. https://doi.org/10.1159/000346521
  30. Gupta BK, Saha AK, Mukherjee S, Saha B. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial. Eur J Pediatr 2020;179:1287-93. https://doi.org/10.1007/s00431-020-03682-9